Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
![](https://investorshub.advfn.com/uicon/323933.png?cb=1618788139)
Friday, August 07, 2020 10:02:08 AM
That is the edge and its a big one which Brilacidin has over newcomers...
Brilacidin, from day one of development by Dr. DeGrado, was formulated to kill and destroy ANY "ENVELOPED VIRUS" existing when formulated or future "Enveloped Virus"...
REMEMBER: Viral cells are attracted to Brilacidin...and Brilacidin "pops the envelope (destroying it), like "a pin pops a balloon"
Destroying the virus on contact...obviously prevents replication and speed of destruction eliminates mutation.
Brilacidin already present in tissue has been shown in RBL tests...to act as a prophylactic (not unlike a Vaccine which develops antibodies which should do the same as Brilacidin...if vaccine works!)
Other potential therapeutics have not shown they could do the same. The mechanism of action appears to be unique to Brilacidin (as was planned when formulated).
Brilacidin was developed as a new synthetic Antibacterial and at the time of development was believed and proving to be a new and effective Antiviral.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM